Skip to main content
. 2022 Jan 27;12(2):219. doi: 10.3390/biom12020219
ADNP activity-dependent neurotrophic protein
β-amyloid peptide
AD Alzheimer´s disease
AIS acute ischemic stroke
APP Alzheimer Aβ precursor protein
ASC adipose tissue-derived mesenchymal stem cells
ASC-CCM concentrated conditioned medium from ASC
ASC-CM conditioned medium from ASC
ASC-EV extracellular vesicles from ASC
BDNF brain-derived neurotrophic factor
BM-MSC bone marrow-derived MSC
CM conditioned medium
CMS chronic mild stress
CNS central nervous system
EAE experimental autoimmune encephalomyelitis
EMA European Medicines Agency
EV extracellular vesicles
FGF-2 fibroblast-growth factor-2
GCI global cerebral ischemia
GMP good manufacturing practices
HLA human leucocyte antigen
HO-1 heme oxygenase-1
IFN-γ interferon-γ
IL Interleukin
iNOS inducible nitric oxide synthase
LPS lipopolysaccharide
MS multiple sclerosis
MSC mesenchymal stem cells
mTBI mild traumatic brain injury
NK natural killer cells
NO nitric oxide
PD Parkinson´s disease
PS1 Presilin1
PI3K phosphoinositol-3-kinase
PKB protein kinase B/Akt
PIP3 phophoinositol-3-phosphate
SCI spinal cord injury
SN substantia nigra
TBI traumatic brain injury
TH tyrosine hydroxylase
TMEV MS model of Theiler’s murine encephalomyelitis virus
TNF-α tumor necrosis factor-α
RhoGEF Rho guanine nucleotide exchange factor
VIP vasoactive intestinal peptide